cougar forte
bayer ag - dispergovateľný koncentrát - diflufenican 280 g/l; flufenacet 280 g/l
cougar forte
bayer ag - dispergovateľný koncentrát - diflufenican 280 g/l; flufenacet 280 g/l
plateen 41,5 wg
bayer ag - dispergovateľný granulát - metribuzin 175 g/kg; flufenacet 240 g/kg
plateen 41,5 wg
bayer ag - dispergovateľný granulát - metribuzin 175 g/kg; flufenacet 240 g/kg
pepaxti
oncopeptides ab - melphalan flufenamide hydrochloride - viacnásobný myelóm - antineoplastické činidlá - pepaxti is indicated, in combination with dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least three prior lines of therapies, whose disease is refractory to at least one proteasome inhibitor, one immunomodulatory agent, and one anti-cd38 monoclonal antibody, and who have demonstrated disease progression on or after the last therapy. for patients with a prior autologous stem cell transplantation, the time to progression should be at least 3 years from transplantation (see section 4.
afluditen 25 mg/ml
bb pharma a.s., Česká republika - flufenazín - 68 - antipsychotica (neuroleptica)
haloperidol-richter
gedeon richter plc., maďarsko - haloperidol - 68 - antipsychotica (neuroleptica)
haloperidol-richter
gedeon richter plc., maďarsko - haloperidol - 68 - antipsychotica (neuroleptica)
haloperidol-richter 1,5 mg
gedeon richter plc., maďarsko - haloperidol - 68 - antipsychotica (neuroleptica)
haloperidol decanoat-richter
gedeon richter plc., maďarsko - haloperidol - 68 - antipsychotica (neuroleptica)